Iron Deficiency Anaemia in Pregnant Patients Presenting for Antenatal Care

May 17, 2022 updated by: Christella Alphonsus, University of Cape Town

A Cross-sectional Prospective Study of the Prevalence of Iron Deficiency Anaemia in Pregnant Patients Presenting for Antenatal Care at a Secondary Level Institution, Mowbray Maternity Hospital

This is a cross-sectional, prospective study of iron deficiency anaemia among pregnant patients presenting for antenatal care at a secondary level institution in the Western Cape, Mowbray Maternity Hospital, over a one-week period.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

132

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • South Africa
    • Western Cape
      • Cape Town, Western Cape, South Africa, 7700
        • Mowbray Maternity Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

This study will include all consenting patients presenting to the Antenatal Clinic at Mowbray Maternity Hospital, for antenatal care, during the one-week period of recruitment.

Description

Inclusion Criteria:

  • All women presenting to the antenatal care services at Mowbray Maternity Hospital over the period of study recruitment.
  • ≥ 18 years of age.
  • Screen as anaemic (World Health Organisation <11g/dl) on bedside finger-prick haemoglobin.
  • Who consent to participate.

Exclusion Criteria:

Patients who refuse to participate, and those under the age of 18 years will be excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of anaemia among all women presenting for antenatal care at a secondary level institution in the Western Cape, Mowbray Maternity Hospital, during a one-week period.
Time Frame: One week
Proportion
One week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Cape Town

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 31, 2022

Primary Completion (ACTUAL)

February 4, 2022

Study Completion (ACTUAL)

February 4, 2022

Study Registration Dates

First Submitted

November 29, 2021

First Submitted That Met QC Criteria

December 14, 2021

First Posted (ACTUAL)

December 15, 2021

Study Record Updates

Last Update Posted (ACTUAL)

May 18, 2022

Last Update Submitted That Met QC Criteria

May 17, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UCape Town

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data will be shared by PI

IPD Sharing Time Frame

Not limoited

IPD Sharing Access Criteria

Contact PI

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe